A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbiditiesCapsule Summary

• मुख्य लेखकों: Dea Metko, BSc (लेखक), Maha Alkofide, MD (लेखक), Mohannad Abu-Hilal, MD, MRCP (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2024-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Dupilumab is a monoclonal antibody approved for the treatment of moderate-to-severe atopic dermatitis (MtS-AD). Various clinical trials have established the effectiveness and safety of dupilumab for the treatment MtS-AD; however, the real-world experiences of patients treated with dupilu...